Edition:
United States

Codexis Inc (CDXS.OQ)

CDXS.OQ on NASDAQ Stock Exchange Global Select Market

4.30USD
26 May 2017
Change (% chg)

$-0.10 (-2.27%)
Prev Close
$4.40
Open
$4.38
Day's High
$4.45
Day's Low
$4.30
Volume
10,356
Avg. Vol
34,439
52-wk High
$5.25
52-wk Low
$3.69

Latest Key Developments (Source: Significant Developments)

Codexis reports Q1 non-GAAP loss per share $0.13
Tuesday, 9 May 2017 04:05pm EDT 

May 9 (Reuters) - Codexis Inc :Codexis reports financial results for the first quarter of 2017.Q1 non-GAAP loss per share $0.13.Q1 loss per share $0.18.Q1 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.Codexis Inc says Codexis is affirming its financial guidance for 2017.FY 2017 earnings per share view $-0.31, revenue view $51.3 million -- Thomson Reuters I/B/E/S.  Full Article

Codexis announces pricing of public offering of common stock
Friday, 7 Apr 2017 09:15am EDT 

Codexis Inc : Codexis announces pricing of public offering of common stock .Says public offering of 5.50 million common shares priced at $4.00 per share.  Full Article

Codexis Q4 loss per share $0.13
Thursday, 9 Mar 2017 04:05pm EST 

Codexis Inc : Codexis reports 2016 fourth quarter and full year financial results . Q4 loss per share $0.13 . Q4 earnings per share view $-0.11 -- Thomson Reuters I/B/E/S . Codexis Inc - total revenues for Q4 of 2016 were $10.0 million . Codexis Inc - research and development (research and development) expenses were $6.0 million for Q4 of 2016 compared with $5.2 million for q4 of 2015 . Codexis Inc- sees 2017 total revenues of $50 million to $53 million . Codexis Inc- sees 2017 product sales of $21 million to $23 million, an increase of 37% to 50% over 2016 . Codexis Inc- sees 2017 gross margin on product sales between 37% and 39% .Codexis inc- sees 2017 total operating expenses for research and development and sg&a to increase by 6% to 8%.  Full Article

Codexis to supply Tate & Lyle proprietary enzyme for food ingredient production
Tuesday, 6 Dec 2016 07:00am EST 

Codexis Inc :Codexis Inc - has entered into an exclusive agreement with Tate & Lyle to supply a proprietary enzyme for use in company's food ingredient production.  Full Article

Codexis reports Q2 adj. earnings per share $0.12
Tuesday, 9 Aug 2016 04:05pm EDT 

Codexis Inc : Codexis reports financial results for the second quarter of 2016 . Q2 earnings per share $0.05 . Sees FY 2016 revenue $46 million to $49 million . Q2 non-GAAP earnings per share $0.12 . Q2 earnings per share view $0.03 -- Thomson Reuters I/B/E/S .Q2 revenue $16 million versus I/B/E/S view $15.1 million.  Full Article

Codexis reports Q1 loss per share $0.17
Monday, 9 May 2016 04:05pm EDT 

Codexis Inc : Codexis reports financial results for the first quarter of 2016 . Q1 non-GAAP loss per share $0.11 . Q1 loss per share $0.17 . Q1 revenue $8.0 million versus I/B/E/S view $7.5 million .Q1 earnings per share view $-0.15 -- Thomson Reuters I/B/E/S.  Full Article

Codexis Inc gives FY 2016 revenue guidance in line with analysts' estimates
Thursday, 3 Mar 2016 04:05pm EST 

Codexis Inc:Financial outlook for Fy 2016 is for another year of growth with revenues in the range of $46 million to $49 million.Expect gross margin for Fy 2016 to be between 80% and 85% of total revenues.FY 2016 REV VIEW $47.64 MLN -- THOMSON REUTERS I/B/E/S.  Full Article

Codexis signs multi-year extension of contract with merck to supply enzyme used in manufacture of sitagliptin
Friday, 18 Dec 2015 07:00am EST 

Codexis Inc:Announces the signing of an agreement extension with Merck Sharp & Dohme Corp to license and supply a proprietary enzyme used in the manufacturing process for sitagliptin.  Full Article

Codexis Inc reaffirms FY 2015 revenue guidance
Wednesday, 4 Nov 2015 04:05pm EST 

Codexis Inc:Affirms FY 2015 expectation for revenues to be in the range of $41 million to $44 million.FY 2015 revenue of $42 million - Thomson Reuters I/B/E/S.  Full Article

Codexis Inc raises FY 2015 revenue outlook
Tuesday, 11 Aug 2015 04:05pm EDT 

Codexis Inc:Expects FY 2015 total revenues to be between $41 and $44 million, this compares favorably with prior guidance of total revenues of $39 to $42 million.FY 2015 revenue of $41 million - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Codexis reports Q1 non-GAAP loss per share $0.13

* Codexis reports financial results for the first quarter of 2017